ExScale Biospecimen Solutions Company
ExScale Biospecimen Solutions provide the market with process knowledge and unique chemical technology for large-scale, uncomplicated preparation of DNA and/or RNA. ExScale introduces automated, next-generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded (FFPE) tissue sections using paramagnetic beads. The technology enables serial extraction of DNA and RNA from the same biospecimen where the isolated nucleic acids are of optimal quality for next-generation sequencing and other downstream applications.
Technology:
P4 Medicine
Industry:
Health Care, Science and Engineering
Headquarters:
Uppsala, Uppsala Lan, Sweden
Founded Date:
2012-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
1
Estimated Revenue:
$1M to $10M
Last Funding Type:
Pre-Seed
Register and Claim Ownership